RxDoctor Payments Data

Joshua Madsen, MD

Anesthesiology · Fresno, CANPI 1487792537

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Edwards Lifesciences at 54.0% of the total. Reporting peaked in 2019 at $220 and has fallen 64.4% since, to $78 in 2025.

$607in general payments, 2019–2025

Across 10 payments — averaging $60.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$328
  • Merck$125
  • Eagle Pharmaceuticals, Inc.$44
  • Mindray DS USA, Inc.$42
  • Abiomed$38
  • Medtronic$16
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$607100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences4$328
Merck1$125
Eagle Pharmaceuticals, Inc.1$44
Mindray DS USA, Inc.1$42
Abiomed1$38
Medtronic1$16
Octapharma USA, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$607 in reported general payments places this provider in the 80th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California →

Medicare billing

Part B allowed, 2024
$97,850
Medicare patients
468
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Fresno

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →